In an inflammatory microenvironment, MHC II molecules can be aberrantly expressed by non-hematopoietic cells, including melanoma cells (17), which, similar to PD-L1 expression in melanoma, can occur following secretion of IFNγ by NK cells and cytotoxic T cells (18, 19). Here, IFNG is linked to melanoma.